cProcessing bodies (PBs) are conserved cytoplasmic aggregations of translationally repressed mRNAs assembled with mRNA decay factors. The aggregation of mRNA-protein (mRNP) complexes into PBs involves interactions between low-complexity regions of protein components of the mRNPs. In Saccharomyces cerevisiae, the carboxy (C)-terminal Q/N-rich domain of the Lsm4 subunit of the Lsm1-7 complex plays an important role in PB formation, but the C-terminal domain of Lsm4 in most eukaryotes is an RGG domain rather than Q/N rich. Here we show that the Lsm4 RGG domain promotes PB accumulation in human cells and that symmetric dimethylation of arginines within the RGG domain stimulates this process. A mutant Lsm4 protein lacking the RGG domain failed to rescue PB formation in cells depleted of endogenous Lsm4, although this mutant protein retained the ability to assemble with Lsm1-7, associate with decapping factors, and promote mRNA decay and translational repression. Mutation of the symmetrically dimethylated arginines within the RGG domain impaired the ability of Lsm4 to promote PB accumulation. Depletion of PRMT5, the primary protein arginine methyltransferase responsible for symmetric arginine dimethylation, including Lsm4, resulted in loss of PBs. We also uncovered the histone acetyltransferase 1 (HAT1)-RBBP7 lysine acetylase complex as an interaction partner of the Lsm4 RGG domain but found no evidence of a role for this complex in PB metabolism. Together, our findings suggest a stimulatory role for posttranslational modifications in PB accumulation and raise the possibility that mRNP dynamics are posttranslationally regulated. P osttranscriptional gene regulation is critical for maintaining proper cellular function. The combination of proteins interacting with mRNAs making up the messenger ribonucleoproteins (mRNPs) determines the state of the mRNP; whether it is actively translated, targeted for mRNA decay, or stored in a translationally repressed state. These alternative fates of mRNPs can be regulated globally or in an mRNP-specific manner in response to intracellular or extracellular cues (1, 2).Eukaryotic cytoplasmic mRNAs are bound on the 5= cap by the translation initiation complex eIF4F and on the 3= poly(A) tail by poly(A)-binding protein (PABP), which act synergistically to stimulate translation (3). A major pathway of mRNA turnover in eukaryotes initiates by mRNA deadenylation (4, 5). This is followed by decapping by the Dcp2-decapping complex and ultimately 5=-to-3= exonucleolytic decay by Xrn1 (6). The Lsm1-7 complex associates with its cofactor Pat1 (known as PatL1 in humans) and the 3= ends of deadenylated mRNAs and promotes decapping by a mechanism that is not fully understood but involves the association of Lsm1-7-Pat1 with decapping enhancers (7-11).mRNAs that are targeted for deadenylation-initiated mRNA decay can accumulate in the cytoplasm in RNP granules known as processing bodies (PBs) (12). These granules are highly dynamic and sensitive to the level of mRNP intermediates undergoing deadenyla...